Immerse yourself in the realm of clinical trial risk management with our comprehensive training programme, designed as an ideal pathway into this field. Tailored for individuals familiar with ICH Guidelines for Good Clinical Practice (ICH GCP E6(R2)) and ICH Guideline on General Considerations for Clinical Studies (ICH E8(R1)), this course pivots towards applying risk management principles to clinical trials. It's equally beneficial for professionals with quality or risk management experience from diverse disciplines. Prior experience in clinical trials and familiarity with the ICH Guidelines is recommended.
Our course focuses intensively on the practical aspects of clinical trial risk management. Engage in workshops designed to provide firsthand experience in deploying risk management techniques within a clinical trial context. Guiding you through this journey are seasoned quality professionals, imparting theoretical knowledge through their rich practical experiences.
Tutors will be comprised of (click the photos for biographies):
Rosemarie is an experienced global leader in Quality, Audit, Compliance, and Quality Risk Management and provides consultancy services to pharma and Biotech. Previously she held the position of EVP Global Quality at Worldwide Clinical trials where she directed and oversaw quality and compliance programs for all areas of the Worldwide organization encompassing QMS, quality risk management, audit, training, standards and controlled documents, data integrity, audit and inspection readiness, process improvement, and quality metrics. Previously Rosemarie was the Chief Quality Officer at Nordic Nanovector, where she established the QA strategy and operations for development of radiopharmaceutical products.
Rosemarie holds a Masters in Bioethics and Medical Law from St Mary's University, London, and a Batchelor of Science in Biochemistry from University College Galway. She is eligible to be an QP for IMPs. She is a Fellow of Research Quality Assurance and Fellow of Royal Society of Biology. She is the current chair of RQA GCP committee.
Cathy Dove is a Quality & Risk Management Industry expert, providing risk and quality management consultancy along with GCP audits and bespoke training to a range of Pharma and Biotech clients. She is an RQA GCP Committee member and member of the EFGCP Quality Working Group, working within Clinical Quality Compliance and Risk Management.
Cathy has over 30 years Global Pharmaceutical Clinical Research expertise (Phase I-IV) both from Pharma and CRO and is also a pharmacist. During her career, Cathy has held various global senior leadership positions (including 2 years based in Singapore). Her responsibilities included project quality management, internal audits across all Clinical Research Services, preparation, hosting, and follow-up of inspections from all major regulatory inspectorates and sponsor audits.
As an independent consultant Cathy continues to support clients with inspection readiness, risk and quality management projects, sponsor oversight and vendor audits, complex system and for cause site audits and bespoke training courses.
Cathy has been a course tutor for the RQA GCP Auditing Course for over 20 years and is the course principle for the Risk Management in Clinical Trials course.
Associate Director, GD Quality Management (GCP), Regeneron Pharmaceuticals Inc
View pop upPatricia has over 20 years of experience in clinical research within a variety of roles. Patricia is a Fellow of the Research Quality Association, where she is an active member of the GCP Committee.
Please note timings may be subject to alteration.
Introduction to the clinical trial risk management process. The concepts of risk management. A brief review of the regulations and guidelines that describe risk management requirements in clinical trials.
CRASH 2 was a non-commercial trial to investigate the effects of antifibrinolytic treatment on death and transfusion requirement in trauma patients.
How to determine what is critically important to the successful completion of the trial.
Identification and management of clinical trial risk with limited staff and resources.
How to manage risk in a large, siloed environment making best use of the available data sources.
What are the QTLs and how to define them.
How to develop more effective audit programs focusing on the areas of highest risk to the conduct of clinical trials.
Areas of risk that are often under-estimated in clinical trials.
How to adapt your site auditing techniques for RBM trials and determining the acceptability of clinical trial data.
This course will be run completely online. You will receive an email with a link to our online system, which will house your licensed course materials and access to the remote event.
Please note this course will run in UK timezone.
You will need a stable internet connection, a microphone and a webcam.
Develop
Good Clinical Laboratory Practice (GCLP) eBooklet
Good Clinical Practice Regulatory Authority Inspections eBooklet
Introduction to Good Clinical Laboratory Practice (GCLP) elearning
Introduction to Good Clinical Practice (GCP) elearning
Introduction to Managing an Audit Programme elearning
Introduction to Quality Risk Management (QRM) elearning
Introduction to the Audit Process elearning
Management of the Training and Competency of Personnel in GxP and Research Environments eBooklet